| Literature DB >> 31289782 |
Rula Btoush1, Diane R Brown2, Jennifer Tsui3, Lindsey Toler4, Jennifer Bucalo5.
Abstract
Purpose: The purpose of this study was to examine knowledge, attitudes, barriers, and facilitators for human papillomavirus (HPV) vaccination among Latina mothers of HPV vaccine-eligible children in low-income urban areas, as well as useful strategies to improve HPV vaccination.Entities:
Keywords: adolescent health; cervical cancer; health behavior; papillomavirus vaccines
Year: 2019 PMID: 31289782 PMCID: PMC6608702 DOI: 10.1089/heq.2018.0058
Source DB: PubMed Journal: Health Equity ISSN: 2473-1242
Focus Group Questions
| PART 1: KNOWLEDGE OF HPV |
| 1. Before we talk about the HPV vaccine, what do you know about HPV infection? |
| |
| PART II: KNOWLEDGE OF HPV VACCINATION |
| 1. What do you know about HPV vaccination? |
| |
| 2. How did you learn about the HPV vaccination? |
| 3. Has the doctor or nurse talked to you about the HPV vaccine? How did they discuss it with you? |
| PART III: VIEWS TOWARD THE HPV VACCINE |
| 1. How do you feel about the HPV vaccine overall? |
| 2. Tell us about the decision-making process in vaccinating your children. |
| |
| 3. How do you feel about vaccinating adolescent girls? |
| 4. How do you feel about vaccinating adolescent boys? |
| 5. What would discourage mothers from vaccinating their children against the HPV infection? |
| 6. What would motivate mothers to vaccinate their children against the HPV infection? |
| 7. How can we best reach out to Latina mothers to educate them about the HPV vaccine? |
| PART III: QUESTIONS BASED ON HPV VACCINATION STATUS |
| Questions for mothers who have not to initiate the HPV vaccine: |
| 1. You are in this group because you have not started the HPV vaccine for your adolescent child(ren). Could you discuss your decision with us? |
| |
| 2. What information or factors influence your future decision making about the HPV vaccine? |
| Questions for mothers who have initiated but not competed the HPV vaccine: |
| 1. You are in this group because you have started the HPV vaccine for your adolescent child(ren) but did not complete all three shots. Could you discuss your decision with us? |
| |
| 2. Do you intend on completing the vaccination shots? Explain why. |
| 3. What information or factors influence your future decision or ability to complete the vaccine? |
| Questions for mothers who have competed the HPV vaccine: |
| 1. You are in this group because you have completed the HPV vaccine for your adolescent child(ren). Could you discuss your decision with us? |
| |
| 2. Are there information or factors that assisted you in completing the HPV vaccine? |
HPV, human papillomavirus.
Characteristics of the Study Sample
| % | ||
|---|---|---|
| Origin | ||
| Caribbean | 55 | 41.7 |
| South American | 22 | 16.6 |
| Central American | 55 | 41.7 |
| Country of Origin | ||
| Columbia | 5 | 3.8 |
| Cuba | 7 | 5.3 |
| Dominican republic | 20 | 15.2 |
| Ecuador | 35 | 26.5 |
| El Salvador | 7 | 5.3 |
| Guatemala | 1 | 0.8 |
| Honduras | 3 | 2.3 |
| Mexico | 11 | 8.3 |
| Peru | 12 | 9.1 |
| Uruguay | 2 | 1.5 |
| The United States–Puerto Rico | 28 | 21.2 |
| Venezuela | 1 | 0.8 |
| Language | ||
| English | 19 | 15.2 |
| Spanish | 112 | 84.8 |
| Education | ||
| High school or less | 85 | 64.4 |
| More than high school | 47 | 35.6 |
| Employment status | ||
| Unemployed | 93 | 70.5 |
| Full time | 20 | 15.2 |
| Part time | 19 | 14.4 |
| Income (annual) | ||
| <$14,000 | 108 | 81.8 |
| $15,000−$29,000 | 13 | 9.8 |
| >$30,000 | 11 | 8.4 |
| Marital status | ||
| Married/partnered | 82 | 62.1 |
| Single | 26 | 19.7 |
| Divorced/separated/widowed | 24 | 18.2 |
| Insurance status | ||
| Private insurance | 19 | 14.4 |
| Public (Medicaid/Medicare) | 45 | 34.1 |
| Uninsured | 68 | 51.5 |
| Ever heard of HPV vaccine | ||
| Yes | 73 | 55.3 |
| No | 59 | 44.7 |
| HPV vaccination status | ||
| Not vaccinated | 95 | 72.0 |
| Initiated by not completed | 17 | 12.9 |
| Completed | 19 | 14.4 |
Bivariate Analysis of Ever Hearing About and Receiving the Human Papillomavirus Vaccine
| Ever heard of HPV vaccine, % | Received HPV vaccination, % | |
|---|---|---|
| Mother's age | ||
| <40 years old | 50.0 | 30.6 |
| 40 years old or more | 61.7 | 23.3 |
| Hispanic origin | ||
| Caribbean | 61.8 | 30.9 |
| Central/South American | 50.6 | 24.7 |
| Language | ||
| English | 90.0[ | 45.0[ |
| Spanish | 49.1 | 24.1 |
| Education | ||
| High school or less | 51.2 | 29.3 |
| More than high school | 62.0 | 24.0 |
| Employment | ||
| Unemployed | 52.7 | 22.6 |
| Employed | 61.5 | 38.5 |
| Income (annual) | ||
| $14,000 or less | 49.1[ | 24.1 |
| More than $14,000 | 83.3 | 41.7 |
| Mother's marital status | ||
| Married/partnered | 56.1 | 29.3 |
| Single/separated/divorced | 54.0 | 24.0 |
| Insurance status | ||
| Insured | 64.1[ | 39.1[ |
| Uninsured | 47.1 | 16.2 |
| Ever heard of the HPV vaccine | ||
| Yes | — | 46.6[ |
| No | — | 3.4 |
This table includes row percentages (e.g., among English speakers, 90% ever heard of the HPV vaccine).
p≤0.05, **p≤0.01, ***p≤0.001 using Chi-square test.
Summary of Study Results
| Knowledge about the HPV infection |
| Knowledge: |
| • Overall limited knowledge and confusion about HPV infection, methods of transmission, and its consequences. |
| • Most recognized the link between HPV infection and cervical cancer, but not other HPV-related cancers. |
| • Some confusion between HPV and HIV. |
| • Uncertainty about the risk factors for the infection and whether it affects women, men, or both genders. |
| • Misinformation about HPV transmission methods: by contact/touching, through childbirth, when exchanging underwear, by blood transfusion, by sharing needles, and through public places. |
| Varying levels of knowledge: |
| • CL mothers were more knowledgeable about the HPV infection and its consequences. |
| • SCA mothers lacked knowledge and had more misinformation about the HPV infection. |
| Sources of information: |
| • The most common source of information is the child's doctor. |
| • Other sources: internet, TV commercials, and through knowing others who were infected with HPV. |
| Knowledge about the HPV vaccine |
| Knowledge: |
| • Fifty-five percent have ever heard of the HPV vaccine, 27% had adolescent child(ren) who had received at least one dose, and 14% had child(ren) who had completed the HPV vaccine three-dose series. |
| • Most mothers were aware of the purpose for HPV vaccination (to prevent the HPV infection and cancer). |
| • Lack of information about the HPV vaccine guidelines (age, gender, number of doses, dosing intervals, etc.). |
| Varying levels of knowledge: |
| • Higher rates of ever hearing of the HPV vaccine among the insured, English speakers, and higher annual income. |
| • Higher rates of receiving the HPV vaccine among the insured and mothers who ever heard of the HPV vaccine. |
| Sources of information: |
| • The most common source is the child's doctor. |
| • Other sources: posters, brochures, internet, TV commercials, peers, and family members. |
| • The majority did not see HPV vaccine advertisements in Spanish magazines. |
| • Some concern that schools do not inform parents about the HPV vaccine. |
| Attitudes toward the HPV vaccine |
| • Overall high acceptability for the vaccine for both female and male adolescent children. |
| • Concern that the HPV vaccination age of 11 is too young; preferred to be given around the time of puberty. |
| • Agreement that the vaccine does not encourage sexual activity. |
| • Mothers are the primary and sole people making decisions about their children's vaccines. |
| Barriers and facilitators of HPV vaccination |
| Barriers |
| • Lack of recommendation from the HCP for the HPV vaccine. |
| • Lack of available information on the HPV vaccine in Spanish. |
| • Concern about potential adverse and vaccine safety. |
| Facilitators: |
| • HCP recommendation as the strongest facilitator. |
| • The mothers' desire to protect their children from the HPV infection and HPV-related cancers. |
| Strategies to improve HPV vaccination |
| • Improving HCP recommendation through providing information, addressing concerns about side effects, and presenting a strong recommendation and support for the HPV vaccine. |
| • Using print materials on the vaccine such as booklets and brochures. |
| • Community outreach activities to educate mothers about the HPV vaccine. |
| • School-based approaches to educate mothers about the HPV vaccine. |
| • Using mobile technology (e.g., apps and text messaging) to educate mothers about the HPV vaccine and remind them of upcoming appointments. |
| • Setting up follow-up visits immediately after receiving the first dose to improve HPV vaccine completion. |
CL, Caribbean Latina; SCA, Central/South American; HCP, health care provider.